Genetic engineering & bio-selection

01Overview and value chain

Markers: [EC: GMO Directive 2001/18/EC | OECD: agri-biotech | Regulator: USDA-APHIS (USA), EFSA (EU), MOA-China (China)]

Genetic engineering and bio-selection are transforming global agriculture by accelerating the development of resilient, high-yielding crop varieties.

1. Genomic selection to rapidly identify elite breeding lines.
2. CRISPR-Cas9 multiplex editing for complex polygenic traits.
3. Marker-assisted breeding to bypass lengthy field trials.
4. RNA interference (RNAi) traits for built-in pest resistance.

Value chain levels

┌──────────────────────────────────────────────────────────────────────────────┐
│                  Germplasm sequencing and trait discovery                    │
└──────────────────────────────────────────────────────────────────────────────┘
                                       │
                                       ▼
┌──────────────────────────────────────────────────────────────────────────────┐
│               Gene editing (CRISPR) or Marker-Assisted Selection             │
└──────────────────────────────────────────────────────────────────────────────┘
                                       │
                                       ▼
┌──────────────────────────────────────────────────────────────────────────────┐
│                    Greenhouse and field trial validation                     │
└──────────────────────────────────────────────────────────────────────────────┘
                                       │
                                       ▼
┌──────────────────────────────────────────────────────────────────────────────┐
│                Commercial seed multiplication and distribution               │
└──────────────────────────────────────────────────────────────────────────────┘

Cross-cutting technologies of the sector:

• Genomic selection: Using whole-genome models to predict plant performance.
• Multiplex CRISPR editing: Modifying multiple genes simultaneously.
• Speed breeding: Extending photoperiods to achieve multiple generations per year.

02US

The US leads the global market in commercializing genetically engineered crops, driven by major ag-tech hubs.

Commercialization and Innovation

Companies like Corteva and Inari leverage predictive AI and multiplex gene editing to create next-generation seeds. The USDA APHIS SECURE rule provides a favorable regulatory pathway, exempting many CRISPR-edited crops from the stringent regulations that govern traditional transgenics.

03CN

China aggressively pursues genetic engineering to ensure national food security and reduce reliance on seed imports.

Strategic Seed Security

Syngenta (under ChemChina) and national academies focus on developing high-yield, drought-resistant varieties of rice, wheat, and soybeans. Recent regulatory shifts by the MOA-China have cleared the path for commercial planting of bio-engineered crops, scaling up national bio-selection programs.

04EU

The EU has historically maintained strict GMO regulations but is currently adapting its framework for New Genomic Techniques (NGTs).

NGTs and Sustainable Farming

European companies like Bayer Crop Science and KeyGene focus strongly on marker-assisted selection and NGTs. While traditional transgenics face heavy restrictions, the EU’s evolving stance on CRISPR-edited crops aims to support the Green Deal’s goals of reducing chemical pesticide use through inherent crop resilience.

05Leading companies and research institutes

06Tech stack and innovations

1. Multiplex Editing: Using advanced CRISPR systems to simultaneously alter dozens of genetic loci, optimizing complex traits like water-use efficiency.
2. Speed Breeding: Combining customized LED lighting algorithms and precise temperature control to accelerate the plant growth cycle.

07Value chains and production pipelines

Seed Bio-Selection Pipeline

┌──────────────┐      ┌──────────────┐
│ 1. AI Design │ ───> │ 2. Editing   │
└──────────────┘      └──────────────┘
                             │
                             ▼
┌──────────────┐      ┌──────────────┐
│ 4. Hardening │ <─── │ 3. Tissue Cul│
└──────────────┘      └──────────────┘
       │
       ▼
┌──────────────┐      ┌──────────────┐
│ 5. Nursery   │ ───> │ 6. Retail    │
└──────────────┘      └──────────────┘

Stage 1:

Computational identification of genes associated with the desired trait.

Stage 2:

Agrobacterium-mediated transformation or CRISPR-Cas9 delivery.

Stage 3:

Regeneration of whole plants from single edited cells via in vitro tissue culture.

Stage 4:

Acclimatization and hardening of plantlets in high-humidity growth chambers.

Stage 5:

Scale-up cultivation in automated, climate-controlled commercial greenhouses.

Stage 6:

Distribution to B2B landscaping firms or direct-to-consumer retail sales.